Analysts expect over 2018 rising revenue Rhoen-Klinikum

Tomorrow the German Rhoen-Klinikum will publish its past quarters figures. For this year Rhoen-Klinikum's revenue will be around 1,28 billion euros. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 1,23 billion euros.

Historical revenues and results Rhoen-Klinikum plus estimates 2018

The analysts expect for 2018 a net profit of 45 million euros. Most of the analysts anticipate on a profit per share of 62 cent. The price/earnings-ratio is then 40,48.

Analysts expect a dividend of 0,29 cents per share. Thus the dividend yield equals 1,16 percent. The average dividend yield of the support companies equals a poor 1 percent.

Most recent target prices around 23 euros

Independent Research, Credit Suisse and M.M. Warburg & Co. recently provided recommendations for the stock.

Rhoen-Klinikum's market capitalization is based on the number of outstanding shares around 1,68 billion euros. The Rhoen-Klinikum stock was the past 12 months quite unstable. Since last March the stock is 6 percent lower. This year the stock price moved between 21 and 28 euro. Since 2008 the stock price is almost 74 percent higher.

At 10.23 the stock trades 0,4 percent higher at 25,1 euros.

Price data Rhoen-Klinikum 2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.